Vancomycin

VANCOVIB

COMPOSITION
Vancomycin500MG
SPECIFICATION
FORMINJECTABLE
PACKING1’s
PACKING TYPE
MRP301

DESCRIPTION

Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. [PubChem]

SIDE EFFECTS

The oral LD50 in mice is 5000 mg/kg. The median lethal intravenous dose is 319 mg/kg in rats and 400 mg/kg in mice.

INDICATION

For the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci.